Purchase Order 12405B19P0124
- Not listed
- 10X Genomics, Inc. was awarded a purchase order on September 22, 2018, valued at $12,500 for a 12-month Chromium Assurance Plan covering maintenance and support services for a Chromium Controller instrument (Serial Number 10492). The contract was awarded without set-aside designation under a firm fixed-price arrangement by a civilian federal agency within the Southeast Area. Performance of this service is based in Pleasanton, California, with an ultimate completion date of September 28, 2019....
- The U.S. government awarded a firm fixed-price purchase order valued at $9,808.00 to 10X Genomics, Inc. for one Chromium Genome Chip Kit V2 (48 reactions) on September 19, 2017. The contract, which was performed in Pleasanton, California, carried an ultimate completion date of October 18, 2017. No set-aside designation was applied to this procurement, and the funding was provided by a civilian federal agency within the Southeast Area. 10X Genomics, Inc., a biotechnology company specializing in...
- This is a firm fixed-price purchase order awarded by the National Institute of Child Health and Human Development, a civilian federal agency, to 10X Genomics, Inc., a biotechnology company in Pleasanton, California. The $9,999.00 order is for the Chromium Next GEM product, which is used for advanced single-cell and spatial genomic analysis. 10X Genomics has been awarded multiple federal contracts and task orders from NIH institutes, often with small business set-aside designations, to provide...
- This is a firm fixed-price purchase order contract awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to 10X Genomics, Inc. The contract has a potential value of $14,000.00 and is for the delivery of 10X Genomics' Chromium Assurance Plans, which include their genomic analysis platforms, reagents, instruments, and bioinformatics software. 10X Genomics is a life sciences technology company that...
- 10X Genomics, Inc. has been awarded a firm fixed price purchase order valued at $20,500 by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases. The contract is for the Chromium IX/X Assurance Plan to be performed in Pleasanton, California through February 2025 with no set-aside designation used. As a manufacturer of single-cell and spatial analysis products and services, 10X Genomics will deliver its Chromium...
- This is a firm fixed price purchase order awarded by the Northeast Area of a civilian federal agency to 10X Genomics, Inc. for $21,888.50. The award is for 10X Genomics Chromium consumables to support single cell sequencing. The contract has no set-aside designation and is intended to supply these genomics products and services to support the agency's biomedical research efforts, particularly by the National Institutes of Health and its various institutes and centers. 10X Genomics is a life...
- The Food and Drug Administration (FDA) awarded a $90,562 firm fixed-price purchase order to 10X Genomics, Inc. for a Chromium X instrument and accessory kit, with performance completion targeted for September 7, 2023. The award, issued on September 7, 2022, was made without a set-aside designation and specifies Laurel, Maryland as the place of performance. 10X Genomics is a leading biotechnology company headquartered in Pleasanton, California, specializing in advanced genomic analysis...
- This firm fixed price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to 10X Genomics, Inc., a life sciences technology company. The $12,000.00 contract is for a 12-month assurance plan for the company's CHROMIUM X platform. It does not have a set-aside designation. 10X Genomics has provided a range of genomics analysis products and services to federal agencies, including the NIH,...
- This is a firm fixed-price purchase order contract awarded by the Veterans Integrated Service Network 20, a civilian agency within the U.S. Department of Veterans Affairs, to 10X Genomics, Inc., a for-profit biotechnology company based in Pleasanton, California. The contract is for a 12-month Chromium IX Assurance Plan, with a ceiling value of $9,000.00. The contract does not have a set-aside designation. 10X Genomics is a leading provider of advanced genomic analysis platforms, reagents, and...
- This is a firm fixed price purchase order awarded by the Animal and Plant Health Inspection Service (APHIS), a civilian agency within the U.S. Department of Agriculture, to 10X Genomics, Inc. for an Chromium IX/X Instrument Assurance Plan. The $15,000.00 contract has an ultimate completion date of August 17, 2025. 10X Genomics, a life sciences technology company, provides genomic analysis platforms, reagents, instruments, and bioinformatics software to enable single-cell and spatial analysis...
The U.S. government awarded a $7,500 firm fixed-price purchase order to 10X Genomics, Inc. for a 12-month Chromium Assurance Plan covering instrument serial number 10492, with performance from September 29, 2019 through September 28, 2020. The contract, issued on March 28, 2019, supports a civilian federal agency within the Southeast Area and will be performed at 10X Genomics' headquarters in Pleasanton, California. No set-aside designation was applied to this award. 10X Genomics is a biotechnology company specializing in advanced genomic analysis platforms and reagents for single-cell and spatial transcriptomics research. The Chromium Assurance Plan represents a service and support agreement for sophisticated scientific instrumentation used in biomedical research. This purchase order aligns with 10X Genomics' broader federal contracting portfolio, which includes substantial work with the National Institutes of Health and its various institutes, including the National Institute on Aging, which maintains a significant indefinite delivery contract with the company valued up to $7 million through 2029. The assurance plan contract demonstrates the government's investment in maintaining critical genomic analysis capabilities that support ongoing federal research initiatives across multiple scientific domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.5k | 3/28/19 |